Nicotinamide adenine dinucleotide (NAD+) is a core coenzyme present in all living cells of the human body. It dynamically transforms between oxidized and reduced states, playing a crucial role in key life processes.
Semaglutide has been shown to significantly reduce weight, especially in patients with diabetes.
A new drug can mimic the effects of exercise to promote muscle growth, improve physical performance, and potentially treat conditions caused by lack of exercise, such as obesity and muscle atrophy.
Recent news reports the latest research progress on the next-generation weight loss drug Retatrutide.
Studies showed that, with weekly administration, at week 24, overweight/obese non-diabetic subjects in the retatrutide 12mg group experienced a mean weight loss of 18.7 kg (17.5%); in the secondary endpoint, the retatrutide 12mg group achieved a mean weight loss of 26.2 kg (24.2%) at the end of week 48 treatment.
MT-II is essentially a polypeptide that mimics natural melanocyte-stimulating hormone (MSH). However, its modified form more effectively activates melanocytes in the skin, promoting the production and distribution of melanin granules, thereby deepening skin tone and forming a natural "sunscreen layer." This mechanism differs from traditional topical sunscreens; it fundamentally enhances the skin's own defense system, allowing skin beautification and care to occur simultaneously.
Melanotan II: A Scientific Revolution in Skin Beauty On the path to beauty and health, Melanotan II (MT-II) shines like a ray of light, redefining skin tone and self-protection mechanisms. As a synthetic melanocyte-stimulating hormone receptor agonist, it not only promotes the skin's natural melanin production, giving it a deeper tone, but also strengthens the skin's ability to resist ultraviolet radiation, opening a new chapter in beauty and skincare.